Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia
Standard
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia. / Zielen, Stefan; Duecker, Ruth Pia; Woelke, Sandra; Donath, Helena; Bakhtiar, Sharhzad; Buecker, Aileen; Kreyenberg, Hermann; Huenecke, Sabine; Bader, Peter; Mahlaoui, Nizar; Ehl, Stephan; El-Helou, Sabine M; Pietrucha, Barbara; Plebani, Alessandro; van der Flier, Michiel; van Aerde, Koen; Kilic, Sara S; Reda, Shereen M; Kostyuchenko, Larysa; McDermott, Elizabeth; Galal, Nermeen; Pignata, Claudio; Pérez, Juan Luis Santos; Laws, Hans-Juergen; Niehues, Tim; Kutukculer, Necil; Seidel, Markus G; Marques, Laura; Ciznar, Peter; Edgar, John David M; Soler-Palacín, Pere; von Bernuth, Horst; Krueger, Renate; Meyts, Isabelle; Baumann, Ulrich; Kanariou, Maria; Grimbacher, Bodo; Hauck, Fabian; Graf, Dagmar; Granado, Luis Ignacio Gonzalez; Prader, Seraina; Reisli, Ismail; Slatter, Mary; Rodríguez-Gallego, Carlos; Arkwright, Peter D; Bethune, Claire; Deripapa, Elena; Sharapova, Svetlana O; Lehmberg, Kai; Davies, E Graham; Schuetz, Catharina; Kindle, Gerhard; Schubert, Ralf.
In: J CLIN IMMUNOL, Vol. 41, No. 8, 11.2021, p. 1878-1892.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia
AU - Zielen, Stefan
AU - Duecker, Ruth Pia
AU - Woelke, Sandra
AU - Donath, Helena
AU - Bakhtiar, Sharhzad
AU - Buecker, Aileen
AU - Kreyenberg, Hermann
AU - Huenecke, Sabine
AU - Bader, Peter
AU - Mahlaoui, Nizar
AU - Ehl, Stephan
AU - El-Helou, Sabine M
AU - Pietrucha, Barbara
AU - Plebani, Alessandro
AU - van der Flier, Michiel
AU - van Aerde, Koen
AU - Kilic, Sara S
AU - Reda, Shereen M
AU - Kostyuchenko, Larysa
AU - McDermott, Elizabeth
AU - Galal, Nermeen
AU - Pignata, Claudio
AU - Pérez, Juan Luis Santos
AU - Laws, Hans-Juergen
AU - Niehues, Tim
AU - Kutukculer, Necil
AU - Seidel, Markus G
AU - Marques, Laura
AU - Ciznar, Peter
AU - Edgar, John David M
AU - Soler-Palacín, Pere
AU - von Bernuth, Horst
AU - Krueger, Renate
AU - Meyts, Isabelle
AU - Baumann, Ulrich
AU - Kanariou, Maria
AU - Grimbacher, Bodo
AU - Hauck, Fabian
AU - Graf, Dagmar
AU - Granado, Luis Ignacio Gonzalez
AU - Prader, Seraina
AU - Reisli, Ismail
AU - Slatter, Mary
AU - Rodríguez-Gallego, Carlos
AU - Arkwright, Peter D
AU - Bethune, Claire
AU - Deripapa, Elena
AU - Sharapova, Svetlana O
AU - Lehmberg, Kai
AU - Davies, E Graham
AU - Schuetz, Catharina
AU - Kindle, Gerhard
AU - Schubert, Ralf
N1 - © 2021. The Author(s).
PY - 2021/11
Y1 - 2021/11
N2 - Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and may have a poorer prognosis. In this study, we analyzed mortality and immunity data of 659 A-T patients with regard to IgA deficiency collected from the European Society for Immunodeficiencies (ESID) registry and from 66 patients with classical A-T who attended at the Frankfurt Goethe-University between 2012 and 2018. We studied peripheral B- and T-cell subsets and T-cell repertoire of the Frankfurt cohort and survival rates of all A-T patients in the ESID registry. Patients with A-T have significant alterations in their lymphocyte phenotypes. All subsets (CD3, CD4, CD8, CD19, CD4/CD45RA, and CD8/CD45RA) were significantly diminished compared to standard values. Patients with IgA deficiency (n = 35) had significantly lower lymphocyte counts compared to A-T patients without IgA deficiency (n = 31) due to a further decrease of naïve CD4 T-cells, central memory CD4 cells, and regulatory T-cells. Although both patient groups showed affected TCR-ß repertoires compared to controls, no differences could be detected between patients with and without IgA deficiency. Overall survival of patients with IgA deficiency was significantly diminished. For the first time, our data show that patients with IgA deficiency have significantly lower lymphocyte counts and subsets, which are accompanied with reduced survival, compared to A-T patients without IgA deficiency. IgA, a simple surrogate marker, is indicating the poorest prognosis for classical A-T patients. Both non-interventional clinical trials were registered at clinicaltrials.gov 2012 (Susceptibility to infections in ataxia-telangiectasia; NCT02345135) and 2017 (Susceptibility to Infections, tumor risk and liver disease in patients with ataxia-telangiectasia; NCT03357978).
AB - Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and may have a poorer prognosis. In this study, we analyzed mortality and immunity data of 659 A-T patients with regard to IgA deficiency collected from the European Society for Immunodeficiencies (ESID) registry and from 66 patients with classical A-T who attended at the Frankfurt Goethe-University between 2012 and 2018. We studied peripheral B- and T-cell subsets and T-cell repertoire of the Frankfurt cohort and survival rates of all A-T patients in the ESID registry. Patients with A-T have significant alterations in their lymphocyte phenotypes. All subsets (CD3, CD4, CD8, CD19, CD4/CD45RA, and CD8/CD45RA) were significantly diminished compared to standard values. Patients with IgA deficiency (n = 35) had significantly lower lymphocyte counts compared to A-T patients without IgA deficiency (n = 31) due to a further decrease of naïve CD4 T-cells, central memory CD4 cells, and regulatory T-cells. Although both patient groups showed affected TCR-ß repertoires compared to controls, no differences could be detected between patients with and without IgA deficiency. Overall survival of patients with IgA deficiency was significantly diminished. For the first time, our data show that patients with IgA deficiency have significantly lower lymphocyte counts and subsets, which are accompanied with reduced survival, compared to A-T patients without IgA deficiency. IgA, a simple surrogate marker, is indicating the poorest prognosis for classical A-T patients. Both non-interventional clinical trials were registered at clinicaltrials.gov 2012 (Susceptibility to infections in ataxia-telangiectasia; NCT02345135) and 2017 (Susceptibility to Infections, tumor risk and liver disease in patients with ataxia-telangiectasia; NCT03357978).
KW - Adolescent
KW - Adult
KW - Ataxia Telangiectasia/immunology
KW - B-Lymphocytes/immunology
KW - Child
KW - Child, Preschool
KW - Female
KW - Humans
KW - IgA Deficiency/immunology
KW - IgG Deficiency/immunology
KW - Immunoglobulin A/blood
KW - Immunoglobulin G/blood
KW - Immunoglobulin M/blood
KW - Infant
KW - Lymphocyte Count
KW - Male
KW - Middle Aged
KW - T-Lymphocyte Subsets/immunology
KW - Young Adult
U2 - 10.1007/s10875-021-01090-8
DO - 10.1007/s10875-021-01090-8
M3 - SCORING: Journal article
C2 - 34477998
VL - 41
SP - 1878
EP - 1892
JO - J CLIN IMMUNOL
JF - J CLIN IMMUNOL
SN - 0271-9142
IS - 8
ER -